semaglutide mash GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT FOR SERIOUS LIVER DISEASE Semaglutide, a medication already known for its role in weight management, is now the first GLP-1 therapy approved to treat (Metabolic Dysfunction–Associated FDA Grants Accelerated Approval of

Post Tags: Diabetes Endocrinology GLP-1 Obesity Posted In: Clinical Updates In Brief Second Opinions

Circadian rhythm of homocysteine: A study in healthy adults showed that homocysteine levels vary by about 3mol/L over the course of a day

Results vary, but MEDVi's personalized approach gives patients the best chance at lasting success

Wegovy Ozempic and Wegovy both contain the same active ingredient, semaglutide

Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

DNA testing for the child and parents is recommended to confirm the genotyping of the family